Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | HINT1 | P49773 | 1/20 | 0.42 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.42 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.39 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.39 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.39 |
| ▸ | GRIK5 | Q16478 | 1/20 | 0.39 |
| ▸ | P2RY6 | Q15077 | 3/20 | 0.38 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.38 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.38 |
| ▸ | NT5E | P21589 | 1/20 | 0.38 |
| ▸ | MARS1 | P56192 | 2/20 | 0.38 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24547473 | 1.00 | MEN1 (0.54) | MEN1USP2POLBKMT2ALMNA | |
| SCHEMBL24547637 | 1.00 | MEN1 (0.54) | MEN1USP2POLBKMT2ALMNA | |
| SCHEMBL27206625 | 1.00 | MEN1 (0.54) | MEN1USP2POLBKMT2ALMNA | |
| SCHEMBL26974862 | 1.00 | MEN1 (0.54) | MEN1USP2POLBKMT2ALMNA | |
| SCHEMBL24583359 | 1.00 | MEN1 (0.54) | MEN1USP2POLBKMT2ALMNA | |
| SCHEMBL27192927 | 1.00 | MEN1 (0.54) | MEN1USP2POLBKMT2ALMNA | |
| SCHEMBL24547616 | 0.82 | SMN1; SMN2 (0.55) | MEN1USP2POLBKMT2ALMNA | |
| SCHEMBL24584234 | 0.82 | SMN1; SMN2 (0.55) | MEN1USP2POLBKMT2ALMNA | |
| SCHEMBL24547568 | 0.82 | SMN1; SMN2 (0.55) | MEN1USP2POLBKMT2ALMNA | |
| SCHEMBL24583403 | 0.81 | SMN1; SMN2 (0.59) | MEN1USP2POLBKMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11858956-B2 | 6-aza-nucleoside prodrugs as antiviral agents for treating virus infections | SOUTHERN RESEARCH INSTITUTE (US) | 2024-01-02 | — | — | US | disclosed |
| US-20220204545-A1 | 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS | OREGON HEALTH AND SCIENCE UNIVERSITY | 2022-06-30 | — | — | US | disclosed |
| WO-2022133323-A1 | 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS | SOUTHERN RESEARCH INSTITUTE (US) | 2022-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204545-A1 | 6-AZA-NUCLEOSIDE PRODRUGS AS ANTIVIRAL AGENTS FOR TREATING VIRUS INFECTIONS | MTAP, GALE, TPMT | MEN1 531/4885USP2 1180/4885POLB 2443/4885 |
| US-11858956-B2 | 6-aza-nucleoside prodrugs as antiviral agents for treating virus infections | MTAP, GALE, TPMT | MEN1 531/4885USP2 1180/4885POLB 2443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.